337 results
DEFA14A
BMY
Bristol-Myers Squibb Co.
22 Apr 24
Additional proxy soliciting materials
8:16am
STRATEGY & GOVERNANCE Conducted a revised global ESG materiality assessment Expanded ESG operating model to further align with company strategy
424B5
BMY
Bristol-Myers Squibb Co.
16 Feb 24
Prospectus supplement for primary offering
4:34pm
assessment of the likelihood of timely payment of interest when due and the payment of principal on the maturity date. Any downgrade or withdrawal
424B2
mkvd38885hhl7l9s
13 Feb 24
Prospectus for primary offering
8:00am
SC TO-T
EX-99
b49tcl08z c8fqs2lt
25 Jan 24
Third party tender offer statement
8:13am
8-K
EX-99.1
qg8ohcqu
8 Jan 24
Regulation FD Disclosure
10:29am
424B5
s87f741saq1f3fx hzzp
1 Nov 23
Prospectus supplement for primary offering
4:16pm
424B3
4qdkefsy
30 Oct 23
Prospectus supplement
8:05am
DFAN14A
lyiq1gk0n76ur
10 Oct 23
Additional proxy materials by non-management
6:48am